Correlation Between Vytrus Biotech and Oryzon Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vytrus Biotech and Oryzon Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vytrus Biotech and Oryzon Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vytrus Biotech SA and Oryzon Genomics SA, you can compare the effects of market volatilities on Vytrus Biotech and Oryzon Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vytrus Biotech with a short position of Oryzon Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vytrus Biotech and Oryzon Genomics.

Diversification Opportunities for Vytrus Biotech and Oryzon Genomics

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vytrus and Oryzon is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Vytrus Biotech SA and Oryzon Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oryzon Genomics SA and Vytrus Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vytrus Biotech SA are associated (or correlated) with Oryzon Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oryzon Genomics SA has no effect on the direction of Vytrus Biotech i.e., Vytrus Biotech and Oryzon Genomics go up and down completely randomly.

Pair Corralation between Vytrus Biotech and Oryzon Genomics

Assuming the 90 days trading horizon Vytrus Biotech SA is expected to generate 0.7 times more return on investment than Oryzon Genomics. However, Vytrus Biotech SA is 1.42 times less risky than Oryzon Genomics. It trades about 0.01 of its potential returns per unit of risk. Oryzon Genomics SA is currently generating about -0.27 per unit of risk. If you would invest  222.00  in Vytrus Biotech SA on August 25, 2024 and sell it today you would earn a total of  0.00  from holding Vytrus Biotech SA or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Vytrus Biotech SA  vs.  Oryzon Genomics SA

 Performance 
       Timeline  
Vytrus Biotech SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vytrus Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Oryzon Genomics SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oryzon Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Vytrus Biotech and Oryzon Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vytrus Biotech and Oryzon Genomics

The main advantage of trading using opposite Vytrus Biotech and Oryzon Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vytrus Biotech position performs unexpectedly, Oryzon Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oryzon Genomics will offset losses from the drop in Oryzon Genomics' long position.
The idea behind Vytrus Biotech SA and Oryzon Genomics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings